Innate Pharma
IPHA
$2.31
Share price
-6.85%
Change (1 day)
-21.69%
Change (1 year)
Categories
Innate Pharma (IPHA) - P/B ratio
P/B ratio as of May 2024 : 3.25
According to Innate Pharma
's latest financial reports the company has a price-to-book ratio of 3.25.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Innate Pharma - P/B ratio (from 2009 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 4.01 | -22.22% |
| 2022-12-31 | 5.16 | 56.7% |
| 2021-12-31 | 3.29 | 87.79% |
| 2020-12-31 | 1.75 | -18.85% |
| 2019-12-31 | 2.16 | -24.1% |
| 2018-12-31 | 2.85 | -9.83% |
| 2017-12-31 | 3.16 | -65.59% |
| 2016-12-31 | 9.17 | -9.26% |
| 2015-12-31 | 10.1 | 80.42% |
| 2014-12-31 | 5.60 | -0.42% |
| 2013-12-31 | 5.63 | 59.72% |
| 2012-12-31 | 3.52 | 136.27% |
| 2011-12-31 | 1.49 | 13.75% |
| 2010-12-31 | 1.31 | -31.84% |
| 2009-12-31 | 1.92 |